The mid-year conference’s goal was to bring together a promising group of 75 private and microcap companies in 25 different healthcare sectors with a prominent group of European and U.S. institutional investor groups.
Neomatrix of Irvine, Calif., has developed a fully automated, non-invasive device to assess a patient’s risk of developing breast cancer.
The U.S. Preventive Services Task Force recommended this week that women should begin getting routine mammograms at the age of 50 instead of the previously recommended age of 40.
Power3 Medical Products, a company specializing in disease detection through the analysis of proteins, has filed for three patents on its blood test for the early detection of breast cancer.
Copyright © 2025 | WordPress Theme by MH Themes